UNKNOWN ENDO GIA SULU
Report
- Report Number
- 1219930-2021-04258
- Event Type
- Injury
- Date Received
- October 14, 2021
- Date of Event
- May 26, 2021
- Report Date
- October 14, 2021
- Manufacturer
- COVIDIEN LP LLC NORTH HAVEN
- Product Code
- GDW
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IS
- Reporter Occupation
- OTHER
Narratives
TITLE: EARLY OUTCOMES AND MID-TERM SAFETY OF ONE ANASTOMOSIS GASTRIC BYPASS ARE COMPARABLE WITH ROUX-EN-Y GASTRIC BYPASS: A SINGLE CENTER EXPERIENCE SOURCE: RECEIVED: 2 JANUARY 2021 / REVISED: 24 MAY 2021 /ACCEPTED: 26 MAY 2021 # THE AUTHOR(S), UNDER EXCLUSIVE LICENCE TO SPRINGER SCIENCE+BUSINESS MEDIA, LLC, PART OF SPRINGER NATURE 2021 OBESITY SURGERY (2021) 31:3786¿3792 HTTPS://DOI.ORG/10.1007/S11695-021-05508-5. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
ACCORDING TO A LITERATURE SOURCE OF STUDY PERFORMED BETWEEN FEBRUARY 2012 AND DECEMBER 2018, WHICH WAS A RETROSPECTIVE STUDY THAT COMPARED THE RESULTS OF PATIENTS UNDERGOING ONE ANASTOMOSIS GASTRIC BYPASS (OAGB) AND ROUX-EN-Y GASTRIC BYPASS (RYGB), ALL PROCEDURES WERE PERFORMED LAPAROSCOPICALLY. IT WAS NOTED THERE WERE 314 PATIENTS; 132 UNDERWENT PRIMARY LAPAROSCOPIC RYGB AND 182 HAD OAGB. A TRI-STAPLER WITH PURPLE OR TAN RELOADS AND A STAPLER FROM A DIFFERENT MANUFACTURER WERE USED FOR THE GASTRIC POUCH, THE GASTRO-JEJUNOSTOMY ANASTOMOSIS AND THE JEJUNO-JEJUNOSTOMY ANASTOMOSIS. COMPLICATIONS INCLUDED: BLEEDING AND MARGINAL ULCER. ONE PATIENT WITH BLEEDING REQUIRED REOPERATION. TWO PATIENTS WITH PERFORATED MARGINAL ULCER REQUIRED REOPERATION. THE AVERAGE LENGTH OF HOSPITAL STAY FOR THE RYGB GROUP WAS 3.58 DAYS AND 4.06 DAYS FOR THE OAGB BATCH. NO OTHER COMPLICATIONS WERE RELATED TO THE DEVICE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1528840 | UNKNOWN ENDO GIA SULU | STAPLE, IMPLANTABLE | GDW | COVIDIEN LP LLC NORTH HAVEN | UNKNOWN ENDO GIA SULU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 40 YR | Hospitalization| R |